tetraiodothyroacetic acid has been researched along with lactic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharali, DJ; Davis, FB; Davis, PJ; Dyskin, E; Hercbergs, A; Lansing, L; Mousa, SA; Mousa, SS; Yalcin, M | 1 |
| Bharali, DJ; Bridoux, A; Davis, FB; Davis, PJ; Dyskin, E; Glinskii, A; Glinsky, GV; Hercbergs, AH; Lansing, L; Lin, HY; Ma, J; Mousa, SA; Mousa, SS; Yalcin, M | 1 |
| Bharali, DJ; Davis, PJ; Mousa, SA; Yalcin, M | 1 |
| Bharali, DJ; Darwish, NH; Davis, PJ; Debreli Coskun, M; Keating, KA; Lin, HY; Mousa, SA; Sudha, T; Yalcin, M | 1 |
4 other study(ies) available for tetraiodothyroacetic acid and lactic acid
| Article | Year |
|---|---|
Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Topics: Animals; Carcinoma, Renal Cell; Cell Growth Processes; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Humans; Kidney Neoplasms; Lactic Acid; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays | 2009 |
Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Medullary; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Excipients; Female; Hemoglobins; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Thyroid Neoplasms; Thyroxine; Xenograft Model Antitumor Assays | 2010 |
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine | 2013 |
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Dynamic Light Scattering; Female; Humans; Lactic Acid; Mice, Nude; Nanoparticles; Paclitaxel; Pancreatic Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays | 2017 |